Meclizine Hydrochloride Tablet
Product Images NDC 67296-2250

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 67296-2250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Tablets Bottle))

Package Label-principal Display Panel (12.5 mg (100 Tablets Bottle))
Each tablet contains 12.5 mg meclizine hydrochloride. This medication is distributed by a pharmaceutical company based in Princeton-Hightstown Road, East Windsor, NJ. The tablets should be stored at 20 to 25°C (68 to 77°F) in a tight, light-resistant container. They come in a pack of 100 tablets and the usual dosage should be followed as per the accompanying prescribing information. The tablets are manufactured in India and are meant for use as directed by a healthcare professional.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))
This text is a prescription label for Meclizine Hydrochloride tablets manufactured by AUROBINDO. The tablets contain 25 mg of meclizine dihydrochloride, equivalent to 21.07 mg of meclizine free base. The usual dosage for vertigo is between 25 mg to 100 mg in divided doses daily based on clinical response. The medication should be kept in a tight, light-resistant container with a child-resistant closure, stored at 20° to 25°C (68° to 77°F). The label also includes information on dispensing and keeping the medication out of the reach of children. It is distributed by Aurobindo Pharma USA, Inc., made in India. The label mentions the importance of printing GTIN, serial number, expiry date, and Lot in human-readable along with the 2D Data Matrix during packing.*
FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))
The text provides information about a medication tablet containing 50 mg of a substance identified as meciizine distributed by a company named fyirehioridssavalnt. It also includes the NDC code, distribution location, storage instructions, and dosage information. The product is defined for use in the USP with child-resistant features. The tablets are to be stored between 20 – 25°C (68 – 77°F) and have a specific code for manufacturing. Additionally, it mentions a usual dosage range and instructions for labeling details on the packaging. The medication is made in India.*
FDA Label Image

Chemical Structure (Meclazine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.